Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Consolidated Statements of Operations [Abstract]
Revenue	$ 0	$ 0
Operating expenses:
Research and development	45,227	46,371
General and administrative	22,148	15,823
Total operating expenses	67,375	62,194
Loss from operations	(67,375)	(62,194)
Interest expense	(471)	(468)
Interest and other income, net	3,029	1,908
Accretion of discount on investments, net	2,763	2,419
Net loss	$ (62,054)	$ (58,335)
Net loss per share - basic (in dollars per share)	$ (0.66)	$ (0.73)
Net loss per share - diluted (in dollars per share)	$ (0.66)	$ (0.73)
Weighted-average common shares outstanding - basic (in shares)	93,549,884	79,453,519
Weighted-average common shares outstanding - diluted (in shares)	93,549,884	79,453,519